about us
Operations Management refers to the control of operational processes. The processes convert inputs (material, information, financial resources) into outputs (products, services) embedded in a transformation system that consists of equipment, information systems and people. We mainly focus on industrial transformation processes, services processes and health care processes.
The operations management function holds the primal responsibility for the production of goods and services – the fundamental raison d’être of an organization. As such it is the integrating link between various other functions such as management strategy, product and service development, engineering, procurement, marketing, human resource management, accounting, finance, etc.
EVENTS
Past events
-
date_range
28/10/2019 17:00 - 18:00
KBI - Doctoraatsverdediging Sarah Van der Auweraer
"Spare part inventory management using Service Maintenance information" -
date_range
28/10/2019 15:00 - 16:00
KBI - Doctoral Research Seminar in Operations Management by Prof. Aris Syntetos (Cardiff Business School, Cardiff University, Cardiff, UK)
"Stock keeping unit fill rate specification" -
date_range
27/09/2019 12:00 - 13:00
KBI - "Meet the jury" seminar by Alessandro Agnetis (Dipartimento di Ingegneria dell'Informazione e Scienze Matematiche, Università di Siena, Siena, Italy)
"Scheduling problems with unreliable jobs and machines"
research chairs
The Research Centre for Operations Management hosts:
GlaxoSmithKline (GSK) Vaccines Research Chair on Operations Management
The Atlas Copco research chairs
The Janssens Pharmaceutica Research Chair on Pandemic Preparedness
In the picture:
Romero day 2022: What's the deal with Vaccine Inequity?
We have seen unprecedented developments in vaccine development, but equitable vaccine access and distribution continues to be a challenge and a major point of contention during the COVID-19 pandemic. This event addresses this issue in two ways: (i) bring the audience up to speed on the latest developments and challenges facing global vaccine distribution; and (ii) inviting a transdisciplinary audience of researchers and the public to tackle the questions in a group discussion.
March 17th, 2022